Journal
CELLS
Volume 12, Issue 17, Pages -Publisher
MDPI
DOI: 10.3390/cells12172180
Keywords
folic acid; transsulfuration; oxidative stress; nitric oxide; biomarkers; chronic obstructive pulmonary disease; homocysteine; asymmetric dimethylarginine; symmetric dimethylarginine; ornithine
Categories
Ask authors/readers for more resources
Published on 30th June 2023, our study conducted a systematic review and meta-analysis to examine the association between circulating metabolites and chronic obstructive pulmonary disease (COPD). The findings showed that patients with stable COPD had lower levels of methionine and folic acid, and higher levels of homocysteine and cysteine compared to healthy controls. Additionally, COPD was associated with higher concentrations of ADMA, SDMA, and ornithine. These alterations in metabolites within the arginine, transsulfuration, and folic acid pathways could serve as useful indicators for assessing nitric oxide dysregulation and oxidative stress, as well as identifying novel treatment targets in COPD.
There is an increasing interest in biomarkers of nitric oxide dysregulation and oxidative stress to guide management and identify new therapeutic targets in patients with chronic obstructive pulmonary disease (COPD). We conducted a systematic review and meta-analysis of the association between circulating metabolites within the arginine (arginine, citrulline, ornithine, asymmetric, ADMA, and symmetric, SDMA dimethylarginine), transsulfuration (methionine, homocysteine, and cysteine) and folic acid (folic acid, vitamin B-6, and vitamin B-12) metabolic pathways and COPD. We searched electronic databases from inception to 30 June 2023 and assessed the risk of bias and the certainty of evidence. In 21 eligible studies, compared to healthy controls, patients with stable COPD had significantly lower methionine (standardized mean difference, SMD = -0.50, 95% CI -0.95 to -0.05, p = 0.029) and folic acid (SMD = -0.37, 95% CI -0.65 to -0.09, p = 0.009), and higher homocysteine (SMD = 0.78, 95% CI 0.48 to 1.07, p < 0.001) and cysteine concentrations (SMD = 0.34, 95% CI 0.02 to 0.66, p = 0.038). Additionally, COPD was associated with significantly higher ADMA (SMD = 1.27, 95% CI 0.08 to 2.46, p = 0.037), SDMA (SMD = 3.94, 95% CI 0.79 to 7.08, p = 0.014), and ornithine concentrations (SMD = 0.67, 95% CI 0.13 to 1.22, p = 0.015). In subgroup analysis, the SMD of homocysteine was significantly associated with the biological matrix assessed and the forced expiratory volume in the first second to forced vital capacity ratio, but not with age, study location, or analytical method used. Our study suggests that the presence of significant alterations in metabolites within the arginine, transsulfuration, and folic acid pathways can be useful for assessing nitric oxide dysregulation and oxidative stress and identifying novel treatment targets in COPD. (PROSPERO registration number: CRD42023448036.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available